(Q30444416)

21 June 2017

1 reference

title

Hematopoietic growth factors in clinical hematology (English)

1 reference

21 June 2017

Hematopoietic Growth Factors in Clinical Hematology (English)

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

21 November 2022

author name string

E. Niskanen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777217

21 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

full work available at URL

21 June 2017

http://www.tandfonline.com/doi/pdf/10.3109/07853899109148093

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

21 November 2022

1 reference

21 June 2017

volume

23

1 reference

21 June 2017

issue

6

1 reference

21 June 2017

page(s)

615-624

1 reference

Radioimmunoassay of erythropoietin

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Some chemical properties of human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Anemia induces accumulation of erythropoietin mRNA in the kidney and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Interleukin 3-dependent mediator release in basophils triggered by C5a.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Recombinant human macrophage colony-stimulating factor (M-CSF) requires subliminal concentrations of granulocyte/macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Erythropoietin for patient refusing blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Erythropoietin treatment of anemia associated with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Recombinant human erythropoietin for patients with AIDS treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Treatment of cyclic neutropenia with granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Regional assignment of the erythropoietin gene to human chromosome region 7pter----q22.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148093

Annals of clinical laboratory science

21 January 2018

1

5

91

Kazal L A.

1975

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

The cloning of normal ?Mast? cells in tissue culture

21 November 2022

6

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

The growth of mouse bone marrow cells in vitro

21 November 2022

7

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

The role of carbohydrate in erythropoietin action

21 November 2022

10

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells

21 November 2022

18

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells

21 November 2022

20

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils

21 November 2022

23

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Hierarchical down-modulation of hemopoietic growth factor receptors

21 November 2022

28

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

21 November 2022

40

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Purification and characterization of human granulocyte colony-stimulating factor (G-CSF).

21 November 2022

61

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells

21 November 2022

64

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

21 November 2022

73

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

21 November 2022

76

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

21 November 2022

77

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Decreased erythropoietin response in patients with the anemia of cancer

21 November 2022

82

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

21 November 2022

86

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report

21 November 2022

89

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

21 November 2022

91

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes

21 November 2022

92

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

21 November 2022

96

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

21 November 2022

97

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor

21 November 2022

103

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Cyclosporine and Recombinant Granulocyte Colony-Stimulating Factor in Severe Aplastic Anemia

21 November 2022

111

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

The New England Journal of Medicine

21 November 2022

116

319

493

Antman K H.

1988

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy

21 November 2022

118

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

21 November 2022

125

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

21 November 2022

137

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Differential effect of GM-CSF and G-CSF in cyclic neutropenia

21 November 2022

143

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia

21 November 2022

144

1 reference

https://api.crossref.org/works/10.3109/07853899109148093

21 November 2022

Identifiers

1 reference

21 June 2017

1 reference